Pressmeddelande

AcouSort’s technology exhibited together with Moeller Medical’s system at Analytica

AcouSort AB today announced its German partner Moeller Medical, a developer and manufacturer of high-precision medical solutions, will exhibit a prototype system for analyzing body fluid at the Analytica trade fair in Munich, March 24-27. The system includes AcouSort’s novel AcouWash technology.

“This will give us a great opportunity to show integration of our acoustic separation technology into new point-of-care diagnostic instrumentation. And further, it will show an example of how we collaborate with our partners,” said AcouSort CEO Dr. Torsten Freltoft.

“At Analytica, we are showcasing how our research prototype system combines automated sample preparation with precise system integration for body fluid analysis. The collaboration with AcouSort supports our goal of developing innovative and application-oriented solutions,” said Ingmar Bott, Head of Innovation & Development at Moeller Medical.

The collaboration between AcouSort and Moeller Medical was originally initiated in 2024 and extended last year when the German company ordered additional separation modules for clean-up of fluid samples for integration into their research prototypes.

At the trade fair Analytica, held in Munich, Germany (March 24-27), Moeller Medical will exhibit its prototype system including AcouSort’s technology for automated sample preparation. Analytica is world's leading trade fair for laboratory technology, analysis, biotechnology and analytics. You may find the Moeller Medical booth in Hall B2.521B.

ABOUT MOELLER MEDICAL
Moeller Medical GmbH is a German-based developer and manufacturer of high-precision medical technology, specializing in both proprietary branded systems for advanced bio-sample management as well as custom OEM (Original Equipment Manufacturer) solutions. Founded in 1949 and headquartered in Fulda, Germany, the company operates within the medical equipment manufacturing industry, focusing on areas such as aesthetic surgery, CSF (Cerebrospinal Fluid) management, and fluid management systems.

ABOUT ACOUSORT
AcouSort AB (corporate registration number 556824-1037) is an innovative technology company focusing on developing products and solutions for integrated preparation of biological samples. With the help of sound waves, the company's products can separate blood cells, concentrate, purify, and stain cells, exosomes, and bacteria from biological samples. The technology of the company's products is acoustofluidics, where sound waves and microfluidics enable automated handling of samples in a range of application areas, from research on new biomarkers to the development of new diagnostic systems for near-patient testing – so-called Point-of Care (POC) systems. The company's commercialization strategy is based on the already proven business model of providing separation modules to diagnostic system manufacturers for integrated sample preparation as well as to continue the commercialization of the company's research instruments. With the help of the company's products and development of point-of-care tests, new diagnostic systems and treatments are enabled, addressing some of the most challenging disease areas of our time: cancer, infectious diseases, and cardiovascular diseases. AcouSort is listed at Nasdaq First North Growth Market. The company’s Certified Adviser is Tapper Partners AB.